LENNAR CORP - B SHS (LEN.B) Fundamental Analysis & Valuation

NYSE:LEN.BUS5260573028

Current stock price

87.415 USD
-0.9 (-1.02%)
Last:

This LEN.B fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. LEN.B Profitability Analysis

1.1 Basic Checks

  • LEN.B had positive earnings in the past year.
  • LEN.B had a positive operating cash flow in the past year.
  • In the past 5 years LEN.B has always been profitable.
  • In the past 5 years LEN.B always reported a positive cash flow from operatings.
LEN.B Yearly Net Income VS EBIT VS OCF VS FCFLEN.B Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • LEN.B has a Return On Assets of 5.98%. This is in the better half of the industry: LEN.B outperforms 66.67% of its industry peers.
  • With a Return On Equity value of 9.37%, LEN.B perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • LEN.B has a Return On Invested Capital of 6.47%. This is comparable to the rest of the industry: LEN.B outperforms 51.67% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LEN.B is in line with the industry average of 9.22%.
Industry RankSector Rank
ROA 5.98%
ROE 9.37%
ROIC 6.47%
ROA(3y)8.44%
ROA(5y)10.1%
ROE(3y)12.66%
ROE(5y)15.59%
ROIC(3y)9.8%
ROIC(5y)11.6%
LEN.B Yearly ROA, ROE, ROICLEN.B Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • LEN.B's Profit Margin of 6.02% is fine compared to the rest of the industry. LEN.B outperforms 68.33% of its industry peers.
  • LEN.B's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 8.09%, LEN.B perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
  • In the last couple of years the Operating Margin of LEN.B has declined.
  • Looking at the Gross Margin, with a value of 10.38%, LEN.B is doing worse than 93.33% of the companies in the same industry.
  • In the last couple of years the Gross Margin of LEN.B has declined.
Industry RankSector Rank
OM 8.09%
PM (TTM) 6.02%
GM 10.38%
OM growth 3Y-27%
OM growth 5Y-11.92%
PM growth 3Y-23.69%
PM growth 5Y-11.09%
GM growth 3Y-20.86%
GM growth 5Y-8.29%
LEN.B Yearly Profit, Operating, Gross MarginsLEN.B Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

6

2. LEN.B Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LEN.B is still creating some value.
  • The number of shares outstanding for LEN.B has been reduced compared to 1 year ago.
  • Compared to 5 years ago, LEN.B has less shares outstanding
  • Compared to 1 year ago, LEN.B has a worse debt to assets ratio.
LEN.B Yearly Shares OutstandingLEN.B Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
LEN.B Yearly Total Debt VS Total AssetsLEN.B Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 3.75 indicates that LEN.B is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.75, LEN.B is doing good in the industry, outperforming 63.33% of the companies in the same industry.
  • The Debt to FCF ratio of LEN.B is 208.46, which is on the high side as it means it would take LEN.B, 208.46 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 208.46, LEN.B is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • LEN.B has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of LEN.B (0.27) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 208.46
Altman-Z 3.75
ROIC/WACC0.73
WACC8.84%
LEN.B Yearly LT Debt VS Equity VS FCFLEN.B Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • LEN.B has a Current Ratio of 8.22. This indicates that LEN.B is financially healthy and has no problem in meeting its short term obligations.
  • LEN.B has a better Current ratio (8.22) than 86.67% of its industry peers.
  • LEN.B has a Quick Ratio of 2.52. This indicates that LEN.B is financially healthy and has no problem in meeting its short term obligations.
  • LEN.B has a better Quick ratio (2.52) than 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 8.22
Quick Ratio 2.52
LEN.B Yearly Current Assets VS Current LiabilitesLEN.B Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

5

3. LEN.B Growth Analysis

3.1 Past

  • The earnings per share for LEN.B have decreased strongly by -49.31% in the last year.
  • The Earnings Per Share has been growing slightly by 0.33% on average over the past years.
  • LEN.B shows a decrease in Revenue. In the last year, the revenue decreased by -3.54%.
  • The Revenue has been growing by 8.74% on average over the past years. This is quite good.
EPS 1Y (TTM)-49.31%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.55%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-13.26%

3.2 Future

  • LEN.B is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.99% yearly.
  • Based on estimates for the next years, LEN.B will show a small growth in Revenue. The Revenue will grow by 7.26% on average per year.
EPS Next Y-15.56%
EPS Next 2Y2.33%
EPS Next 3Y10.78%
EPS Next 5Y25.99%
Revenue Next Year-2.45%
Revenue Next 2Y0.88%
Revenue Next 3Y3.93%
Revenue Next 5Y7.26%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
LEN.B Yearly Revenue VS EstimatesLEN.B Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
LEN.B Yearly EPS VS EstimatesLEN.B Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20 25

4

4. LEN.B Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 12.56, which indicates a correct valuation of LEN.B.
  • LEN.B's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 25.50, LEN.B is valued rather cheaply.
  • LEN.B is valuated reasonably with a Price/Forward Earnings ratio of 10.45.
  • Based on the Price/Forward Earnings ratio, LEN.B is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
  • LEN.B's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.67.
Industry RankSector Rank
PE 12.56
Fwd PE 10.45
LEN.B Price Earnings VS Forward Price EarningsLEN.B Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • LEN.B's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, LEN.B is valued a bit more expensive than 68.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 768.04
EV/EBITDA 8.27
LEN.B Per share dataLEN.B EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)38.22
EPS Next 2Y2.33%
EPS Next 3Y10.78%

6

5. LEN.B Dividend Analysis

5.1 Amount

  • LEN.B has a Yearly Dividend Yield of 2.13%. Purely for dividend investing, there may be better candidates out there.
  • LEN.B's Dividend Yield is a higher than the industry average which is at 1.30.
  • Compared to an average S&P500 Dividend Yield of 1.89, LEN.B has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.13%

5.2 History

  • On average, the dividend of LEN.B grows each year by 26.65%, which is quite nice.
  • LEN.B has paid a dividend for at least 10 years, which is a reliable track record.
  • LEN.B has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)26.65%
Div Incr Years1
Div Non Decr Years15
LEN.B Yearly Dividends per shareLEN.B Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • LEN.B pays out 25.31% of its income as dividend. This is a sustainable payout ratio.
  • LEN.B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP25.31%
EPS Next 2Y2.33%
EPS Next 3Y10.78%
LEN.B Yearly Income VS Free CF VS DividendLEN.B Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
LEN.B Dividend Payout.LEN.B Dividend Payout, showing the Payout Ratio.LEN.B Dividend Payout.PayoutRetained Earnings

LEN.B Fundamentals: All Metrics, Ratios and Statistics

LENNAR CORP - B SHS

NYSE:LEN.B (3/25/2026, 12:43:00 PM)

87.415

-0.9 (-1.02%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)03-12
Earnings (Next)06-15
Inst Owners93.57%
Inst Owner Change-3.44%
Ins Owners0.29%
Ins Owner ChangeN/A
Market Cap21.65B
Revenue(TTM)34.19B
Net Income(TTM)2.06B
Analysts53.08
Price Target103.02 (17.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.13%
Yearly Dividend2.02
Dividend Growth(5Y)26.65%
DP25.31%
Div Incr Years1
Div Non Decr Years15
Ex-Date02-04
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.91%
Min EPS beat(2)-13.73%
Max EPS beat(2)7.91%
EPS beat(4)2
Avg EPS beat(4)-0.42%
Min EPS beat(4)-13.73%
Max EPS beat(4)11.86%
EPS beat(8)5
Avg EPS beat(8)4.01%
EPS beat(12)9
Avg EPS beat(12)8.75%
EPS beat(16)11
Avg EPS beat(16)4.95%
Revenue beat(2)1
Avg Revenue beat(2)-0.1%
Min Revenue beat(2)-3.05%
Max Revenue beat(2)2.85%
Revenue beat(4)3
Avg Revenue beat(4)0.78%
Min Revenue beat(4)-3.05%
Max Revenue beat(4)2.85%
Revenue beat(8)5
Avg Revenue beat(8)0.29%
Revenue beat(12)9
Avg Revenue beat(12)2.51%
Revenue beat(16)11
Avg Revenue beat(16)1.94%
PT rev (1m)-0.63%
PT rev (3m)-4.29%
EPS NQ rev (1m)-0.64%
EPS NQ rev (3m)-40.46%
EPS NY rev (1m)-2.06%
EPS NY rev (3m)-24.93%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-12.44%
Revenue NY rev (1m)-0.78%
Revenue NY rev (3m)-5.46%
Valuation
Industry RankSector Rank
PE 12.56
Fwd PE 10.45
P/S 0.63
P/FCF 768.04
P/OCF 99.84
P/B 0.99
P/tB 1.18
EV/EBITDA 8.27
EPS(TTM)6.96
EY7.96%
EPS(NY)8.37
Fwd EY9.57%
FCF(TTM)0.11
FCFY0.13%
OCF(TTM)0.88
OCFY1%
SpS138.06
BVpS88.68
TBVpS74.01
PEG (NY)N/A
PEG (5Y)38.22
Graham Number117.85
Profitability
Industry RankSector Rank
ROA 5.98%
ROE 9.37%
ROCE 8.55%
ROIC 6.47%
ROICexc 7.33%
ROICexgc 12.52%
OM 8.09%
PM (TTM) 6.02%
GM 10.38%
FCFM 0.08%
ROA(3y)8.44%
ROA(5y)10.1%
ROE(3y)12.66%
ROE(5y)15.59%
ROIC(3y)9.8%
ROIC(5y)11.6%
ROICexc(3y)11.51%
ROICexc(5y)13.4%
ROICexgc(3y)16.28%
ROICexgc(5y)17.35%
ROCE(3y)12.94%
ROCE(5y)15.31%
ROICexgc growth 3Y-14.76%
ROICexgc growth 5Y1.92%
ROICexc growth 3Y-24.72%
ROICexc growth 5Y-5.18%
OM growth 3Y-27%
OM growth 5Y-11.92%
PM growth 3Y-23.69%
PM growth 5Y-11.09%
GM growth 3Y-20.86%
GM growth 5Y-8.29%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 208.46
Debt/EBITDA 2.03
Cap/Depr 140.44%
Cap/Sales 0.55%
Interest Coverage 55.18
Cash Conversion 7.47%
Profit Quality 1.37%
Current Ratio 8.22
Quick Ratio 2.52
Altman-Z 3.75
F-Score5
WACC8.84%
ROIC/WACC0.73
Cap/Depr(3y)126.5%
Cap/Depr(5y)104.2%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.35%
Profit Quality(3y)63.09%
Profit Quality(5y)63.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-49.31%
EPS 3Y-20.53%
EPS 5Y0.33%
EPS Q2Q%-52.55%
EPS Next Y-15.56%
EPS Next 2Y2.33%
EPS Next 3Y10.78%
EPS Next 5Y25.99%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y0.51%
Revenue growth 5Y8.74%
Sales Q2Q%-13.26%
Revenue Next Year-2.45%
Revenue Next 2Y0.88%
Revenue Next 3Y3.93%
Revenue Next 5Y7.26%
EBIT growth 1Y-46.35%
EBIT growth 3Y-26.63%
EBIT growth 5Y-4.23%
EBIT Next Year-17.49%
EBIT Next 3Y10.01%
EBIT Next 5Y18.06%
FCF growth 1Y-98.74%
FCF growth 3Y-79.37%
FCF growth 5Y-63.1%
OCF growth 1Y-90.98%
OCF growth 3Y-59.51%
OCF growth 5Y-44.7%

LENNAR CORP - B SHS / LEN.B Fundamental Analysis FAQ

What is the fundamental rating for LEN.B stock?

ChartMill assigns a fundamental rating of 5 / 10 to LEN.B.


What is the valuation status for LEN.B stock?

ChartMill assigns a valuation rating of 4 / 10 to LENNAR CORP - B SHS (LEN.B). This can be considered as Fairly Valued.


Can you provide the profitability details for LENNAR CORP - B SHS?

LENNAR CORP - B SHS (LEN.B) has a profitability rating of 4 / 10.


Can you provide the financial health for LEN.B stock?

The financial health rating of LENNAR CORP - B SHS (LEN.B) is 6 / 10.


How sustainable is the dividend of LENNAR CORP - B SHS (LEN.B) stock?

The dividend rating of LENNAR CORP - B SHS (LEN.B) is 6 / 10 and the dividend payout ratio is 25.31%.